Arovella Therapeutics (ASX:ALA) has announced that Dr Thomas Duthy is retiring effective 1 July as a non-executive director and chairman of the company to pursue new business opportunities.
Arovella Therapeutics announces the retirement of non-executive chair
June 30, 2025 Australian Biotech
Latest Video
New Stories
-
Tetratherix lists on the ASX following successful IPO
June 30, 2025 - - Australian Biotech -
LTR Pharma achieves key FDA milestone through extractables study
June 30, 2025 - - Australian Biotech -
Arovella Therapeutics announces the retirement of non-executive chair
June 30, 2025 - - Australian Biotech -
The focus on system and patient productivity is a new 'open door' opportunity
June 29, 2025 - - Latest News -
Incoming brief advises minister to dampen expectations on HTA Review
June 29, 2025 - - Latest News -
Incoming brief recommends doing more and reviewing less
June 28, 2025 - - Latest News -
The Dispatched 'Week in Review' Podcast - 27 June
June 27, 2025 - - Podcast